Paper25751786
Can we produce heparin/heparan sulfate biomimetics using "mother-nature" as the gold standard?
Farrugia BL and 3 others. Molecules, 2015. Cited by 24 papers, by iCite.
Cite this record
ConductScience Library. Can we produce heparin/heparan sulfate biomimetics using "mother-nature" as the gold standard? Papers, record 25751786. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25751786
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Can we produce heparin/heparan sulfate biomimetics using "mother-nature" as the gold standard?
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anticoagulants | Major topic |
| Biomimetics | Major topic |
| Heparin | Major topic |
| Heparan Sulfate | Major topic |
| Animals | |
| Humans |
Source PubMed
References124
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22034431 | Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins. | Science | 2011 | https://conductscience.org/library/papers/22034431 | PubMed |
| 2 | 23240683 | Divergent synthesis of 48 heparan sulfate-based disaccharides and probing the specific sugar-fibroblast growth factor-1 interaction. | J Am Chem Soc | 2012 | https://conductscience.org/library/papers/23240683 | PubMed |
| 3 | 18437154 | Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events. | Nat Biotechnol | 2008 | https://conductscience.org/library/papers/18437154 | PubMed |
| 4 | 24697306 | Fluorous-assisted chemoenzymatic synthesis of heparan sulfate oligosaccharides. | Org Lett | 2014 | https://conductscience.org/library/papers/24697306 | PubMed |
| 5 | 21697878 | Synthesis of 3-O-sulfonated heparan sulfate octasaccharides that inhibit the herpes simplex virus type 1 host-cell interaction. | Nat Chem | 2011 | https://conductscience.org/library/papers/21697878 | PubMed |
| 6 | 9468484 | Structural modification of fibroblast growth factor-binding heparan sulfate at a determinative stage of neural development. | J Biol Chem | 1998 | https://conductscience.org/library/papers/9468484 | PubMed |
| 7 | 24770491 | Chemoenzymatic synthesis and structural characterization of 2-O-sulfated glucuronic acid-containing heparan sulfate hexasaccharides. | Glycobiology | 2014 | https://conductscience.org/library/papers/24770491 | PubMed |
| 8 | 10600481 | Localization of glycosaminoglycan substitution sites on domain V of mouse perlecan. | Biochem Biophys Res Commun | 1999 | https://conductscience.org/library/papers/10600481 | PubMed |
| 9 | 16011323 | Heparan sulfate: a complex polymer charged with biological activity. | Chem Rev | 2005 | https://conductscience.org/library/papers/16011323 | PubMed |
| 10 | 24247246 | Bioengineered Chinese hamster ovary cells with Golgi-targeted 3-O-sulfotransferase-1 biosynthesize heparan sulfate with an antithrombin-binding site. | J Biol Chem | 2013 | https://conductscience.org/library/papers/24247246 | PubMed |
| 11 | 19131102 | Enhanced bioactivity of bone morphogenetic protein-2 with low dose of 2-N, 6-O-sulfated chitosan in vitro and in vivo. | Biomaterials | 2009 | https://conductscience.org/library/papers/19131102 | PubMed |
| 12 | 10080934 | Expression of human perlecan domain I as a recombinant heparan sulfate proteoglycan with 20-kDa glycosaminoglycan chains. | Biochem Biophys Res Commun | 1999 | https://conductscience.org/library/papers/10080934 | PubMed |
| 13 | 24038939 | Tailored design and synthesis of heparan sulfate oligosaccharide analogues using sequential one-pot multienzyme systems. | Angew Chem Int Ed Engl | 2013 | https://conductscience.org/library/papers/24038939 | PubMed |
| 14 | 20161474 | Opportunities and challenges in synthetic oligosaccharide and glycoconjugate research. | Nat Chem | 2009 | https://conductscience.org/library/papers/20161474 | PubMed |
| 15 | 24140042 | Vascularization and bone regeneration in a critical sized defect using 2-N,6-O-sulfated chitosan nanoparticles incorporating BMP-2. | Biomaterials | 2014 | https://conductscience.org/library/papers/24140042 | PubMed |
| 16 | 7779094 | Formation of heparan sulfate or chondroitin/dermatan sulfate on recombinant domain I of mouse perlecan expressed in Chinese hamster ovary cells. | Biochem Biophys Res Commun | 1995 | https://conductscience.org/library/papers/7779094 | PubMed |
| 17 | 11545306 | Anticoagulant potential of regioselective derivatized cellulose. | Biomaterials | 2001 | https://conductscience.org/library/papers/11545306 | PubMed |
| 18 | 9020150 | Identification of sites in domain I of perlecan that regulate heparan sulfate synthesis. | J Biol Chem | 1997 | https://conductscience.org/library/papers/9020150 | PubMed |
| 19 | 15658847 | Generation of "neoheparin" from E. coli K5 capsular polysaccharide. | J Med Chem | 2005 | https://conductscience.org/library/papers/15658847 | PubMed |
| 20 | 20729556 | Chemoenzymatic design of heparan sulfate oligosaccharides. | J Biol Chem | 2010 | https://conductscience.org/library/papers/20729556 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41238912 | Engineering a heparin-mimetic biomaterial to promote tissue vascularization. | Commun Biol | 2025 | https://conductscience.org/library/papers/41238912 | PubMed |
| 40705086 | The Role of Heparan Sulfate in Bone Repair and Regeneration. | Calcif Tissue Int | 2025 | https://conductscience.org/library/papers/40705086 | PubMed |
| 32947045 | Advances in the preparation and synthesis of heparin and related products. | Drug Discov Today | 2020 | https://conductscience.org/library/papers/32947045 | PubMed |
| 29290139 | Danger-Associated Molecular Patterns Derived From the Extracellular Matrix Provide Temporal Control of Innate Immunity. | J Histochem Cytochem | 2018 | https://conductscience.org/library/papers/29290139 | PubMed |
| 29160016 | Synthetic Oligosaccharide Libraries and Microarray Technology: A Powerful Combination for the Success of Current Glycosaminoglycan Interactomics. | ChemMedChem | 2018 | https://conductscience.org/library/papers/29160016 | PubMed |
| 28505124 | Structure-Activity Relationships of Bioengineered Heparin/Heparan Sulfates Produced in Different Bioreactors. | Molecules | 2017 | https://conductscience.org/library/papers/28505124 | PubMed |
| 28468328 | Heparin and Heparin-Derivatives in Post-Subarachnoid Hemorrhage Brain Injury: A Multimodal Therapy for a Multimodal Disease. | Molecules | 2017 | https://conductscience.org/library/papers/28468328 | PubMed |
| 28029141 | Glycosaminoglycans and Their Mimetics. | Molecules | 2016 | https://conductscience.org/library/papers/28029141 | PubMed |
| 27744271 | Surprising absence of heparin in the intestinal mucosa of baby pigs. | Glycobiology | 2017 | https://conductscience.org/library/papers/27744271 | PubMed |
| 27461855 | Glycosaminoglycan-Based Biohybrid Hydrogels: A Sweet and Smart Choice for Multifunctional Biomaterials. | Adv Mater | 2016 | https://conductscience.org/library/papers/27461855 | PubMed |
| 26554451 | Mechanical fibrinogen-depletion supports heparin-free mesenchymal stem cell propagation in human platelet lysate. | J Transl Med | 2015 | https://conductscience.org/library/papers/26554451 | PubMed |
Genes18
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25751786
GET https://conductscience.org/api/papers/v1/25751786/references?page=2